Nikkomycin Z
Alternative Names: Nik Z; SP 920704Latest Information Update: 04 Nov 2017
Price :
$50 *
At a glance
- Originator Bayer
- Developer University of Arizona; Valley Fever Solutions
- Class Aminoglycosides; Antifungals; Small molecules
- Mechanism of Action Chitin synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Coccidioidomycosis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Coccidioidomycosis in USA (PO, Capsule)
- 14 Oct 2011 This programme is still active
- 14 Oct 2011 Nikkomycin Z is available for licensing as of 14 Oct 2011. http://valleyfeversolutions.com/